Abstract:Toll-like receptors were discovered as proteins playing a crucial role in the dorsoventral patterning during embryonic development in the Drosophila melanogaster (D. melanogaster) almost 40 years ago. Subsequently, further research also showed a role of the Toll protein or Toll receptor in the recognition of Gram-positive bacterial and fungal pathogens infecting D. melanogaster. In 1997, the human homolog was reported and the receptor was named the Toll-like receptor 4 (TLR4) that recognizes lipopolysaccharide (LPS) of the Gram-negative bacteria as a pathogen-associated molecular pattern (PAMP). Identification of TLR4 in humans filled the long existing gap in the field of infection and immunity, addressing the mystery surrounding the recognition of foreign pathogens/microbes by the immune system. It is now known that mammals (mice and humans) express 13 different TLRs that are expressed on the outer cell membrane or intracellularly, and which recognize different PAMPs or microbe-associated molecular patterns (MAMPs) and death/damage-associated molecular patterns (DAMPs) to initiate the protective immune response. However, their dysregulation generates profound and prolonged pro-inflammatory immune responses responsible for different inflammatory and immune-mediated diseases. This chapter provides an overview of TLRs in the control of the immune response, their association with different diseases, including TLR single nucleotide polymorphisms (SNPs), interactions with microRNAs (miRs), use in drug development and vaccine design, and expansion in neurosciences to include pain, addiction, metabolism, reproduction, and wound healing.

Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential

TLR-Mediated Signal Transduction and Neurodegenerative Disorders

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems

Toll-like Receptors as Versatile Regulators in the Nervous System

Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage

Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases

Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases

The Role of TNF Related Apoptosis-Inducing Ligand in Neurodegenerative Diseases.

Toll-like receptors in inflammation, infection and cancer

Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders

TLR Signaling in Brain Immunity.

Toll like receptor - potential drug targets in infectious disease.

The potential for treg-enhancing therapies in nervous system pathologies

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors

Toll-Like Receptors (TLRs) in Health and Disease: An Overview

Regulation of Toll-Like Receptor (TLR) Signaling Pathway by Polyphenols in the Treatment of Age-Linked Neurodegenerative Diseases: Focus on TLR4 Signaling

The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets

Reprint Of: Microglial Toll-Like Receptors and Alzheimer’s Disease

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders

Alzheimer's disease: The role of T lymphocytes in neuroinflammation and neurodegeneration